Status:
COMPLETED
Dynamic PET acquisition-a Quantitative Technique for Grading of Malignant Tumors and Prediction of Response to Treatment
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
To assess a quantitative kinetic model of FDG uptake measurement using PET in patients with aggressive Non-Hodgkin's lymphoma and cancer of the pancreas, malignancies with known variability in disease...
Eligibility Criteria
Inclusion
- age\>18
- newly diagnosed untreated aggressive NHL
- newly diagnosed untreated cancer of pancreas
Exclusion
- none
Key Trial Info
Start Date :
August 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2010
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00294840
Start Date
August 1 2006
End Date
April 1 2010
Last Update
July 29 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Medical Center
Haifa, Israel